Table 6 Payments to individual- and organisational-level recipients under the JPMA Transparency Guidelines and the ABPI Code (2018)
Comparative JPMA-ABPI recipient categories | JPMA Transparency Guidelines | ABPI Code | |||||
|---|---|---|---|---|---|---|---|
Recipients | Recipient categories | JPMA recipient categories | Total value of payments ($) | Value of payments to named recipients ($) | ABPI recipient categories | Total value of payments ($) | Value of payments to named recipients ($) |
Individual level | Healthcare professionals | Medical personnel | 1,364,162,424.48 (100%) | 249,488,350.76 (18.3%) | Healthcare professionals | 65,300,800.84 (100.0%) | 37,406,101.85 (57.3%) |
Other healthcare personnel | Persons involved in medical operations | Â | Â | Other relevant decision makers | |||
Non-healthcare professions and roles | Life science researchers | Â | Â | No equivalent category | |||
Organisational level | Healthcare organisations | Healthcare organisations | 1,581,648,701.10 (100%) | 1,541,575,712.50 (97.5%) | Healthcare organisations | 106,961,488.98 (100.0%) | 106,914,317.19 (99.9%) |
Unclear if individual or organisational level | Â | No relevant JPMA recipient categories | 42,814,875.43 (100%) | 0 (0%) | Recipients of research and development payments- | 493,470,880.71 (100.0%) | 0 (0%) |
Total | Â | Â | 2,988,626,001.01 (100%), | 1,791,064,063.27 (59.9%) | Â | 665,733,170.5 (100.0%) | 144,320,419.0 (21.7%) |